Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
New 'Your Year' Planners Team Up with Zebra Pen Ahead of the Back-to-School Season
-
BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives
-
SL Green Realty Corp. to Release Second Quarter 2026 Financial Results After Market Close on July 22, 2026
-
DEEP SEA MINERALS CORP. WELCOMES G7 LEADERS’ DECLARATION ON SECURING CRITICAL MINERALS SUPPLY CHAINS
-
FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
-
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
-
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
-
Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY
-
TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST®, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke
-
New 'Your Year' Planners Team Up with Zebra Pen Ahead of the Back-to-School Season
-
BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026
-
Quantum Cyber Issues Letter to Shareholders
-
Schouw & Co. share buy-back programme, week 25 2026
-
Edible Garden's Pickle Party™ Named "Overall Plant-Based Snack Product of the Year" in 2026 Mindful Awards Program
-
Edible Garden's Pickle Party™ Named "Overall Plant-Based Snack Product of the Year" in 2026 Mindful Awards Program
-
CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies
-
European Equity Research Partners starts coverage of Virtualware
-
Form 8.5 (EPT/RI)- Amendment of Gamma Communications Plc
-
GXO to Support Action’s Expansion Across Central and Southern Italy with New Distribution Center in Ferentino
-
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031
-
G2 Goldfields Receives Court Approval for Arrangement With G Mining and Spin-Out of G3 Goldfields
-
Auddia Announces LT350 Advancement Toward First AI Datacenter Deployment, Engaging Fresh Consulting to Lead Engineering and Development
-
WTOP News Names HRCI A Winner Of The Greater Washington Area Top Workplaces 2026 Award
-
Mirasol Provides Exploration Update on Sobek Copper-Gold Project in the Vicuña District, Chile
-
Atlas Energy Corp. Announces Appointments to Subsidiary Board and Extension of TSXV Sandbox Exit Deadline
-
NobelClad Expands Capabilities in the Americas with Weld Overlay Services
-
McFarlane Intersects 155 metres of 0.59 g/t Gold
-
Robinhood Announces Private Offering of $2.0 Billion of Convertible Senior Notes Due 2029
-
QTREX Announces Management Share Purchase Plan
-
Mavenir Launches Agentic Service Assurance Framework to Monitor and Operate the Network
-
Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson
-
Fervo Energy Reports First Quarter 2026 Results
-
Digital Realty Announces Transactions to Drive Continued Platform Growth
-
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening
-
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared wit
-
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
-
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
-
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
-
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
-
TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Trans
-
Brunswick Corporation Announces Operational Updates at Lowell Facility
-
Sparklight Strengthens Local Communities through More than $125,000 in Charitable Giving Fund Grants
-
CureWise Founder and CEO Steve Brown to Speak at Aspen Ideas: Health 2026 and Launch AI-Powered Precision Oncology Platform
-
GXO to Support Action’s Expansion Across Central and Southern Italy with New Distribution Center in Ferentino
-
Gumption Expands California and Larger West Coast Presence with Addition of Commercial Real Estate Finance Veteran John Brooks
-
Sitryx Completes Enrollment in Phase 1b Trial of First-in-Class Oral PKM2 Modulator SYX-5219 in Atopic Dermatitis
-
Lithium Argentina Reports 2026 Annual General Meeting Results
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Alamos Gold Extends High-Grade Mineralization Across Multiple Targets within the Island Gold District which Represent Upside as Potential Sources of Additional Higher-Grade Mill Feed
-
Form 8.5 (EPT/RI)-Treatt Plc
